HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

177Lu-pentixather

a radiolabeled, synthetic CXCR4 ligand for imaging cancer

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - 177Lu-pentixather: 3

Experts

1.	Buck, Andreas K: 1 article (01/2018)
2.	Grigoleit, Götz-Ulrich: 1 article (01/2018)
3.	Götze, Katharina: 1 article (01/2018)
4.	Habringer, Stefan: 1 article (01/2018)
5.	Herhaus, Peter: 1 article (01/2018)
6.	Hänscheid, Heribert: 1 article (01/2018)
7.	Istvanffy, Rouzanna: 1 article (01/2018)
8.	Jeremias, Irmela: 1 article (01/2018)
9.	Keller, Ulrich: 1 article (01/2018)
10.	Kircher, Stefan: 1 article (01/2018)

Related Diseases

1.	Leukemia 01/01/2018 - "In xenografts, CXCR4-directed ERT with 177Lu-Pentixather distributed to leukemia harboring organs and resulted in efficient reduction of leukemia. " 01/01/2023 - "Patients with advanced-stage multiple myeloma, refractory acute leukemia, and diffuse large B-cell lymphoma received a certain amount of 177Lu-Pentixather or 90Y-Pentixather. "
2.	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/21/2023 - "DMS273 small cell lung cancer xenografts in female nude mice treated with 25 μCi/g 177Lu-pentixather induced inhibition of tumor growth and resulted in an increase in overall survival without causing unacceptable normal tissue toxicities. "
3.	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/01/2023 - "Patients with advanced-stage multiple myeloma, refractory acute leukemia, and diffuse large B-cell lymphoma received a certain amount of 177Lu-Pentixather or 90Y-Pentixather. "
4.	Neoplasms (Cancer) 11/21/2023 - "DMS273 small cell lung cancer xenografts in female nude mice treated with 25 μCi/g 177Lu-pentixather induced inhibition of tumor growth and resulted in an increase in overall survival without causing unacceptable normal tissue toxicities. "
5.	Multiple Myeloma 01/01/2023 - "Patients with advanced-stage multiple myeloma, refractory acute leukemia, and diffuse large B-cell lymphoma received a certain amount of 177Lu-Pentixather or 90Y-Pentixather. "

Related Drugs and Biologics

1.	90Y-pentixather